Vadim Kraynov

This inventor holds 32 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Modified Polypeptides. Top assignees: Ambrx, Inc., Scripps Research Institute, Elanco US Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vadim Kraynov. Retrieved from https://idiyas.com/inventor/vadim-kraynov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 10)

% Patents Active = 75.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 7.3

ph-index = 11

Forward Citations = 330(Granted Patents)

Company Filing History:

Scripps Research Institute

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Modified Polypeptides

FGF-21

Relaxin

Insulin

Amino Acids

Therapeutics

Nucleic Acids

Dolastatin Derivatives

Heart Failure

Fibrotic Disorders

Interferon Beta

Labeled Peptides

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622944 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2026-05-12),

2. 11993637 - Modified FGF-21 polypeptides with non-naturally encoded amino acids (2024-05-28),

3. 11786578 - Modified relaxin polypeptides and their uses (2023-10-17),

4. 11542310 - Modified bovine G-CSF polypeptides and their uses (2023-01-03),

5. 11439710 - Nucleic acids encoding modified relaxin polypeptides (2022-09-13),

6. 11420999 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2022-08-23),

7. 11311605 - Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides (2022-04-26),

8. 10961291 - Modified FGF-21 polypeptides and their uses (2021-03-30),

9. 10954270 - Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives (2021-03-23),

10. 10751391 - Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid (2020-08-25),

11. 10702588 - Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain (2020-07-07),

12. 10377805 - Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses (2019-08-13),

13. 10253083 - Therapeutic uses of modified relaxin polypeptides (2019-04-09),

14. 10138283 - Modified bovine G-CSF polypeptides and their uses (2018-11-27),

15. 9975936 - Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids (2018-05-22),

Title: Inventor Vadim Kraynov: Revolutionizing Technology in San Diego

Introduction: Vadim Kraynov is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology.

Latest Patents: Vadim Kraynov holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Vadim Kraynov has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Vadim Kraynov has collaborated with top scientists, engineers, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Vadim Kraynov's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.